Amos Lal

3.6k citations

137 papers · 1.2k indexed · h-index 18

Infectious Diseases top 5%
Neurology top 5%
Pulmonary and Respiratory Medicine top 10%
Surgery
Epidemiology

Co-authors: Ajay Kumar Mishra Kamal Kant Sahu Jamal Akhtar Mohammad Saud Khan Anu Anna George Vijairam Selvaraj Kevin John Ognjen Gajic
Topics: COVID-19 Clinical Research Studies (28 papers)Long-Term Effects of COVID-19 (18 papers)Respiratory Support and Mechanisms (13 papers)
Cited by: Health Informatics Infectious Diseases Neurology
Journals: SHILAP Revista de lepidopterologíaCHEST Journal The American Journal of Medicine
Partner nations: United States India Italy

In The Last Decade

Amos Lal

124 papers receiving 1.2k citations

Peers

Countries citing papers authored by Amos Lal

Since Specialization

Citations

This map shows the geographic impact of Amos Lal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amos Lal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amos Lal more than expected).

Fields of papers citing papers by Amos Lal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amos Lal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amos Lal. The network helps show where Amos Lal may publish in the future.

Co-authorship network of co-authors of Amos Lal

This figure shows the co-authorship network connecting the top 25 collaborators of Amos Lal. A scholar is included among the top collaborators of Amos Lal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amos Lal. Amos Lal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease- A Growing Threat Beyond the Liver 2025 ·Current Atherosclerosis Reports ·(unknown),Amos Lal,Aysha Almas,Om Parkash	0
2	Advances and utility of digital twins in critical care and acute care medicine: a narrative review 2024 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),(unknown),Oğuz Kılıçkaya,Amos Lal	2
3	Use of Sodium-glucose cotransporter 2 (SGLT 2) inhibitor is associated with reduced emergency room visits and hospitalizations in patients with Chronic obstructive pulmonary disease (COPD) and type 2 Diabetes Mellitus 2024 ·Respiratory Medicine ·(unknown),(unknown),(unknown),(unknown),(unknown),Amos Lal,George M. Abraham,(unknown)	5
4	The Diagnostic Accuracy of Metagenomic Next-Generation Sequencing in DiagnosingPneumocystisPneumonia: A Systemic Review and Meta-analysis 2023 ·Open Forum Infectious Diseases ·Aysun Tekin,(unknown),Lucrezia Rovati,Amos Lal,Dana Gerberi,Ognjen Gajic,John C. O’Horo	7
5	Septic shock definitions and associated outcomes in blood culture positive critically ill patients 2023 ·Annals of Translational Medicine ·Amos Lal,(unknown),John C. O’Horo,Tarun D. Singh,Ognjen Gajic,Rahul Kashyap	5
6	Acute on chronic liver failure: prognostic models and artificial intelligence applications 2023 ·Hepatology Communications ·(unknown),Amos Lal,Douglas A. Simonetto,Ognjen Gajic,Alice Gallo de Moraes	2
7	Early machine learning prediction of hospitalized patients at low risk of respiratory deterioration or mortality in community-acquired pneumonia: Derivation and validation of a multivariable model 2023 ·SHILAP Revista de lepidopterología ·Yewande Odeyemi,Amos Lal,Erin F. Barreto,(unknown),Hemang Yadav,Ognjen Gajic,Phillip J. Schulte	4
8	Pulmonary Cryptococcosis and Pulmonary Fibrosis: A Complication of COVID-19 Pneumonia 2023 ·Cureus ·(unknown),(unknown),(unknown),(unknown),Amos Lal	2
9	The impact of the COVID-19 pandemic on ICU clinical trials: a description of one research team’s experience 2023 ·Trials ·Linda L. Chlan,Mary Fran Tracy,(unknown),Amos Lal,Jay Mandrekar	2
10	A Review of Nuclear Imaging in Takotsubo Cardiomyopathy 2022 ·Life ·(unknown),Kevin John,(unknown),(unknown),Anu Anna George,Amos Lal,Ajay Kumar Mishra	6
11	Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials 2022 ·EClinicalMedicine ·Vijairam Selvaraj,Arkadiy Finn,Amos Lal,Mohammad Saud Khan,Kwame Dapaah-Afriyie,Gerardo Carino	57
12	Variation in Use of High-Flow Nasal Cannula and Noninvasive Ventilation Among Patients With COVID-19 2022 ·Respiratory Care ·Michael A. Garcia,Shelsey W. Johnson,(unknown),R. Christopher Sheldrick,Vishakha K. Kumar,Karen Boman,Scott Bolesta,Vikas Bansal,(unknown),(unknown),Amos Lal,(unknown),Sreekanth Cheruku,(unknown),Harry L. Anderson,Joshua L. Denson,Ognjen Gajic,Rahul Kashyap,Allan J. Walkey,(unknown)	4
13	A review of the presentation and outcome of sarcoidosis in COVID-19 2021 ·Journal of Clinical and Translational Research ·(unknown),(unknown),Kevin John,Anu Anna George,(unknown),Ajay Kumar Mishra,Amos Lal,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2
14	Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review 2021 ·Infezioni in Medicina ·Thoyaja Koritala,Vishwanath Pattan,Raghavendra Tirupathi,Ali A. Rabaan,Abbas Al Mutair,Saad Alhumaid,Ramesh Adhikari,(unknown),Nitesh Jain,Vikas Bansal,Aysun Tekin,Simon Zec,Amos Lal,Syed Anjum Khan,Juan Pablo Domecq Garces,Omar Abu Saleh,Salim Surani,(unknown)	15
15	A review of the oresentation and outcome of left ventricular thrombus in COVID-19 infection 2021 ·Journal of Clinical and Translational Research ·(unknown),(unknown),Kevin John,Anu Anna George,(unknown),Kamal Kant,Vijairam Selvaraj,Amos Lal,Ajay Kumar Mishra,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	1
16	F _{IO ₂} Trajectory as a Pragmatic Intermediate Marker in Acute Hypoxic Respiratory Failure 2021 ·Respiratory Care ·Sarah Chalmers,Yewande Odeyemi,Amos Lal,Heyi Li,Ryan D. Frank,Ognjen Gajic,Hemang Yadav	2
17	Testicular Lymphoma: A Rare Cause of a Testicular Mass 2020 ·Journal of College of Physicians And Surgeons Pakistan ·Kamal Kant Sahu,Ajay Kumar Mishra,Amos Lal,(unknown)	2
18	Mesenteric Hematoma: Challenges in Diagnosis and Management 2020 ·Journal of College of Physicians And Surgeons Pakistan ·Kamal Kant Sahu,Ajay Kumar Mishra,Amos Lal,(unknown)	0
19	Unique features concerning the proximal origin of SARS-CoV-2 2020 ·Digital Commons - University of South Florida (University of South Florida) ·Murat Seyran,Damiano Pizzol,Parise Adadi,Tarek Mohamed Abd El‐Aziz,Sk. Sarif Hassan,António G. Soares,Ramesh Kandimalla,Kenneth Lundström,Murtaza M. Tambuwala,Alaa A. A. Aljabali,Amos Lal,Gajendra Kumar Azad,Pabitra Pal Choudhury,Vladimir N. Uversky,Samendra P. Sherchan,Bruce D. Uhal,Nima Rezaei,Adam Brufsky	2
20	Detection of coexisting toxigenic Clostridium difficile and nontyphoidal Salmonella in a healthcare worker with diarrhea: A therapeutic dilemma 2019 ·SHILAP Revista de lepidopterología ·Amos Lal,Raul Davaro,(unknown),(unknown),(unknown)	4

About Amos Lal

Amos Lal is a scholar working on Health Informatics, Critical Care and Intensive Care Medicine and Infectious Diseases, having authored 137 papers that have together received 1.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (28 papers), Long-Term Effects of COVID-19 (18 papers) and Respiratory Support and Mechanisms (13 papers). The work is most often cited by research in Health Informatics (37 citations), Infectious Diseases (478 citations) and Neurology (235 citations). Amos Lal has collaborated with scholars based in United States, India and Italy. Frequent co-authors include Ajay Kumar Mishra, Kamal Kant Sahu, Jamal Akhtar, Mohammad Saud Khan, Anu Anna George, Vijairam Selvaraj, Kevin John, Ognjen Gajic, Arkadiy Finn and Kwame Dapaah-Afriyie. Their work appears in journals such as SHILAP Revista de lepidopterología, CHEST Journal and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact